|
GB8709871D0
(en)
*
|
1987-04-27 |
1987-06-03 |
Turner R C |
Peptides
|
|
AU634716B2
(en)
|
1988-08-01 |
1993-03-04 |
Ciba Corning Diagnostics Corp. |
Method for detection of an analyte using acridinium esters and liposomes
|
|
US5430047A
(en)
*
|
1994-04-07 |
1995-07-04 |
Warner-Lambert Company |
Neurotensin antagonists
|
|
US5968899A
(en)
*
|
1994-06-03 |
1999-10-19 |
Tsumura & Co. |
Medicinal compositions of peptides with EACA or tranexamic acid for enhanced mucosal absorption
|
|
CA2321026A1
(en)
*
|
1998-03-09 |
1999-09-16 |
Zealand Pharmaceuticals A/S |
Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
|
|
US6248527B1
(en)
*
|
1998-10-21 |
2001-06-19 |
Millennium Pharmaceuticals, Inc. |
Method of detecting risk of type II diabetes based on mutations found in carboxypeptidase E
|
|
US6818418B1
(en)
|
1998-12-10 |
2004-11-16 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
|
IL142707A0
(en)
*
|
2000-04-27 |
2002-03-10 |
Pfizer Prod Inc |
Methods of treating obesity using a neurotensin receptor ligand
|
|
US7271153B2
(en)
*
|
2001-06-20 |
2007-09-18 |
Kissei Pharmaceutical Co., Ltd. |
Nitrogenous heterocyclic derivatives, medicinal compositions containing the same, medicinal uses thereof, and intermediates therefor
|
|
WO2003020746A1
(en)
|
2001-08-30 |
2003-03-13 |
Biorexis Pharmaceutical Corporation |
Modified transferrin fusion proteins
|
|
EP2298278B1
(en)
|
2002-06-07 |
2015-11-11 |
Dyax Corp. |
Prevention and reduction of blood loss and inflammatory response
|
|
EP1675878A2
(en)
|
2003-10-24 |
2006-07-05 |
Avidia, Inc. |
Ldl receptor class a and egf domain monomers and multimers
|
|
US20100028995A1
(en)
|
2004-02-23 |
2010-02-04 |
Anaphore, Inc. |
Tetranectin Trimerizing Polypeptides
|
|
EP1793847A2
(en)
|
2004-09-21 |
2007-06-13 |
NascaCell IP GmbH |
Use of microproteins as tryptase inhibitors
|
|
DE102005003687A1
(de)
*
|
2005-01-26 |
2006-07-27 |
Sphingo Tec Gmbh |
Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation
|
|
JP2008538812A
(ja)
*
|
2005-04-11 |
2008-11-06 |
アストラゼネカ アクチボラグ |
方法
|
|
US8119358B2
(en)
*
|
2005-10-11 |
2012-02-21 |
Tethys Bioscience, Inc. |
Diabetes-related biomarkers and methods of use thereof
|
|
EP2231860B1
(en)
|
2007-12-19 |
2011-10-05 |
Affibody AB |
Polypeptide derived from protein a and able to bind pdgf
|
|
MX359570B
(es)
|
2008-11-03 |
2018-10-01 |
Molecular Partners Ag |
Proteinas de union que inhiben la interaccion en el receptor de vegf-a.
|
|
MX2011005963A
(es)
*
|
2008-12-05 |
2011-09-01 |
Angiochem Inc |
Conjugados de neurotensina o analogos de neurotensina y sus usos.
|
|
EP2374003B1
(en)
|
2009-01-07 |
2015-03-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the treatment, the prognostic assessment and the detection of breast cancer
|
|
US9376477B2
(en)
|
2009-08-27 |
2016-06-28 |
Covagen Ag |
IL-17 binding compounds and medical uses thereof
|
|
JP2013509588A
(ja)
*
|
2009-10-29 |
2013-03-14 |
テシス バイオサイエンス， インコーポレイテッド |
２型糖尿病の予防に対して一貫した改善をもたらすタンパク質バイオマーカーおよび脂質代謝物バイオマーカー
|
|
WO2011073214A2
(en)
|
2009-12-14 |
2011-06-23 |
Scil Proteins Gmbh |
A method for identifying hetero-multimeric modified ubiquitin proteins with binding capability to ligands
|
|
UA58612U
(uk)
*
|
2010-06-04 |
2011-04-26 |
Высшее Государственное Учебное Заведение «Украинская Медицинская Стоматологическая Академия» |
Спосіб діагностики інсулінорезистентності у хворих на метаболічний синдром та цукровий діабет 2 типу
|
|
JP5902679B2
(ja)
|
2010-06-08 |
2016-04-13 |
ピエリス アーゲーＰｉｅｒｉｓ Ａｇ |
ＩＬ−４Ｒαに結合する涙液リポカリンムテイン
|
|
RU2745751C2
(ru)
*
|
2015-02-27 |
2021-03-31 |
Сфинготек Гмбх |
Способ прогнозирования риска развития ожирения у субъекта
|